In Vitro Selection and Characterization of <i>Bacillus anthracis</i> Mutants with High-Level Resistance to Ciprofloxacin

Lance B. Price, Amy J. Vogler, Talima Pearson, Joseph D. Busch, James M. Schupp, Paul Keim

Antimicrobial Agents and Chemotherapy · 2003 · 118 citations · 22 references

DOIFull text

Open access

Concepts

Abstract

Mutants of attenuated Bacillus anthracis with high-level ciprofloxacin resistance were isolated using a three-step in vitro selection. Ciprofloxacin MICs were 0.5 micro g/ml for first-step mutants, which had one of two gyrA quinolone resistance-determining region (QRDR) mutations. Ciprofloxacin MICs were 8 and 16 microg/ml for second-step mutants, which had one of three parC QRDR mutations. Ciprofloxacin MICs for third-step mutants were 32 and 64 microg/ml. Mutants for which MICs were 64 microg/ml had one of two additional mutations within the gyrA QRDR or one of two mutations within the gyrB QRDR. Mutants for which MICs were 32 microg/ml had no additional target modifications but showed evidence of enhanced ciprofloxacin efflux.

References

22